• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾病转诊中种族与代谢疾病负担的差异。

Disparities in ethnicity and metabolic disease burden in referrals to nephrology.

作者信息

Chua Yan Ting, Leo Cheang Han, Chua Horng Ruey, Wong Weng Kin, Chan Gek Cher, Vathsala Anantharaman, Gan Ye Lu Mavis, Teo Boon Wee

机构信息

Division of Nephrology, Department of Medicine, National University Hospital, Singapore.

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

出版信息

Singapore Med J. 2025 Jun 1;66(6):301-306. doi: 10.4103/singaporemedj.SMJ-2022-193. Epub 2023 Aug 14.

DOI:10.4103/singaporemedj.SMJ-2022-193
PMID:37675684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12200813/
Abstract

INTRODUCTION

The profile of patients referred from primary to tertiary nephrology care is unclear. Ethnic Malay patients have the highest incidence and prevalence of kidney failure in Singapore. We hypothesised that there is a Malay predominance among patients referred to nephrology due to a higher burden of metabolic disease in this ethnic group.

METHODS

This is a retrospective observational cohort study. From 2014 to 2018, a coordinator and physician triaged patients referred from primary care, and determined co-management and assignment to nephrology clinics. Key disease parameters were collated on triage and analysed.

RESULTS

A total of 6,017 patients were studied. The mean age of patients was 64 ± 16 years. They comprised 57% men; 67% were Chinese and 22% were Malay. The proportion of Malay patients is higher than the proportion of Malays in the general population (13.4%) and they were more likely than other ethnicities to have ≥3 comorbidities, including diabetes mellitus, hypertension, hyperlipidaemia, coronary artery disease and stroke (70% vs. 57%, P < 0.001). Malay and Indian patients had poorer control of diabetes mellitus compared to other ethnicities (glycated haemoglobin 7.8% vs. 7.4%, P < 0.001). Higher proportion of Malay patients compared to other ethnicities had worse kidney function with estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m 2 on presentation (28% vs. 24%, P = 0.003). More ethnic Malay, Indian and younger patients missed appointments.

CONCLUSION

A disproportionately large number of Malay patients are referred for kidney disease. These patients have higher metabolic disease burden, tend to miss appointments and are referred at lower eGFR. Reasons underpinning these associations should be identified to facilitate efforts for targeting this at-risk population, ensuring kidney health for all.

摘要

引言

从基层医疗转诊至三级肾脏病护理的患者情况尚不清楚。在新加坡,马来族患者的肾衰竭发病率和患病率最高。我们推测,由于该族群代谢性疾病负担较高,转诊至肾脏病科的患者中马来族占主导。

方法

这是一项回顾性观察队列研究。2014年至2018年期间,一名协调员和医生对基层医疗转诊的患者进行分类,并确定共同管理方式及分配至肾脏病诊所。在分类时整理关键疾病参数并进行分析。

结果

共研究了6017名患者。患者的平均年龄为64±16岁。其中男性占57%;67%为华裔,22%为马来裔。马来族患者的比例高于其在总人口中的比例(13.4%),且与其他种族相比,他们更有可能患有≥3种合并症,包括糖尿病、高血压、高脂血症、冠状动脉疾病和中风(70%对57%,P<0.001)。与其他种族相比,马来族和印度族患者的糖尿病控制较差(糖化血红蛋白7.8%对7.4%,P<0.001)。与其他种族相比,马来族患者中肾功能较差(估算肾小球滤过率[eGFR]<30 mL/min/1.73 m²)的比例更高(28%对24%,P = 0.003)。更多的马来族、印度族和年轻患者错过预约。

结论

转诊至肾脏病科的马来族患者数量过多。这些患者的代谢性疾病负担更高,往往错过预约,且转诊时eGFR较低。应确定这些关联背后的原因,以便针对这一高危人群采取措施,确保所有人的肾脏健康。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aebe/12200813/22102bbf0353/SMJ-66-301-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aebe/12200813/b78605fd1bf8/SMJ-66-301-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aebe/12200813/22102bbf0353/SMJ-66-301-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aebe/12200813/b78605fd1bf8/SMJ-66-301-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aebe/12200813/22102bbf0353/SMJ-66-301-g002.jpg

相似文献

1
Disparities in ethnicity and metabolic disease burden in referrals to nephrology.肾病转诊中种族与代谢疾病负担的差异。
Singapore Med J. 2025 Jun 1;66(6):301-306. doi: 10.4103/singaporemedj.SMJ-2022-193. Epub 2023 Aug 14.
2
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
Navigating the Global Economic Landscape of Dialysis: A Summary of Expert Opinions from The 4th International Congress of Chinese Nephrologists.透析的全球经济格局剖析:第四届中国肾脏病学家国际大会专家意见综述
Kidney Dis (Basel). 2024 Jul 24;10(5):384-397. doi: 10.1159/000540152. eCollection 2024 Oct.

本文引用的文献

1
Dapagliflozin in Patients with Chronic Kidney Disease.达格列净治疗慢性肾脏病患者。
N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.
2
World Kidney Day 2020: Advances in Preventive Nephrology.2020年世界肾脏日:预防肾脏病学的进展
Ann Acad Med Singap. 2020 Apr;49(4):175-179.
3
Prevalence, determinants and association of unawareness of diabetes, hypertension and hypercholesterolemia with poor disease control in a multi-ethnic Asian population without cardiovascular disease.
在一个没有心血管疾病的多民族亚洲人群中,糖尿病、高血压和高胆固醇血症的知晓率、决定因素及其与疾病控制不佳的关系。
Popul Health Metr. 2019 Dec 5;17(1):17. doi: 10.1186/s12963-019-0197-5.
4
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.卡格列净与 2 型糖尿病和肾病患者的肾脏结局。
N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.
5
Chronic kidney disease epidemic: How do we deal with it?慢性肾病流行:我们该如何应对?
Nephrology (Carlton). 2018 Oct;23 Suppl 4:116-120. doi: 10.1111/nep.13464.
6
Medical costs associated with chronic kidney disease progression in an Asian population with type 2 diabetes mellitus.亚洲2型糖尿病患者慢性肾病进展相关的医疗费用。
Nephrology (Carlton). 2019 May;24(5):534-541. doi: 10.1111/nep.13478.
7
Projecting the Burden of Chronic Kidney Disease in a Developed Country and Its Implications on Public Health.预测发达国家慢性肾脏病的负担及其对公共卫生的影响。
Int J Nephrol. 2018 Jul 4;2018:5196285. doi: 10.1155/2018/5196285. eCollection 2018.
8
Nephrology eConsults for Primary Care Providers: Original Investigation.基层医疗服务提供者的肾脏病电子会诊:原始调查
Can J Kidney Health Dis. 2018 Jan 23;5:2054358117753619. doi: 10.1177/2054358117753619. eCollection 2018.
9
Patient and provider perspectives on the design and implementation of an electronic consultation system for kidney care delivery in Canada: a focus group study.患者与医疗服务提供者对加拿大肾脏护理电子咨询系统设计与实施的看法:一项焦点小组研究
BMJ Open. 2017 Mar 2;7(3):e014784. doi: 10.1136/bmjopen-2016-014784.
10
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.恩格列净与 2 型糖尿病患者的肾脏疾病进展。
N Engl J Med. 2016 Jul 28;375(4):323-34. doi: 10.1056/NEJMoa1515920. Epub 2016 Jun 14.